|
Status |
Public on Mar 01, 2020 |
Title |
The 11q13.5 immune disease risk locus contains a distal enhancer required for Treg-mediated suppression of gut inflammation |
Organism |
Mus musculus |
Experiment type |
Expression profiling by high throughput sequencing Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
32499651 |
Submission date |
Jan 13, 2020 |
Last update date |
Feb 16, 2021 |
Contact name |
Felix Krueger |
E-mail(s) |
fkrueger@altoslabs.com
|
Organization name |
The Babraham Institute
|
Department |
Bioinformatics
|
Street address |
Babraham Hall
|
City |
Cambridge |
ZIP/Postal code |
CB22 3AT |
Country |
United Kingdom |
|
|
Platforms (1) |
GPL17021 |
Illumina HiSeq 2500 (Mus musculus) |
|
Samples (24)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE128198 |
The 11q13.5 immune disease risk locus contains a distal enhancer required for Treg-mediated suppression of gut inflammation [RNA-Seq] |
GSE143515 |
The 11q13.5 immune disease risk locus contains a distal enhancer required for Treg-mediated suppression of gut inflammation [ATAC-Seq] |
|
Relations |
BioProject |
PRJNA600868 |